1. Hepatotoxicity in antineoplastic therapy with mitoxantrone

   Newsletter Article 09 February 2013 Pages: 2 - 2

2. Urticaria and angio-oedema from enalapril and captopril: reports to the CSM

   Newsletter Article 09 February 2013 Pages: 2 - 3

3. Management of benzodiazepine withdrawal syndrome

   Newsletter Article 09 February 2013 Pages: 3 - 3

4. Spontaneous adverse drug reaction reporting on piroxicam

   Newsletter Article 09 February 2013 Pages: 3 - 4

5. β-agonists and theophylline

   Newsletter Article 09 February 2013 Pages: 4 - 4

6. NSAIDs and corticosteroids during pregnancy

   Newsletter Article 09 February 2013 Pages: 4 - 5

7. Caffeine ingestion is not associated with fibrocystic breast disease

   Newsletter Article 09 February 2013 Pages: 5 - 5

8. Amiodarone

   Newsletter Article 09 February 2013 Pages: 5 - 5

9. Antidepressants, tricyclic

   Newsletter Article 09 February 2013 Pages: 5 - 6

10. Anti-inflammatories, non-steroidal

    Newsletter Article 09 February 2013 Pages: 6 - 6

11. Aspirin

    Newsletter Article 09 February 2013 Pages: 6 - 6

12. Azapropazone

    Newsletter Article 09 February 2013 Pages: 6 - 6

13. Baclofen overdose

    Newsletter Article 09 February 2013 Pages: 6 - 7

14. Benzodiazepines

    Newsletter Article 09 February 2013 Pages: 7 - 7

15. Betaxolol

    Newsletter Article 09 February 2013 Pages: 7 - 7

16. Bleomycin see Doxorubicin

    Newsletter Article 09 February 2013 Pages: 7 - 7

17. Bleomycin

    Newsletter Article 09 February 2013 Pages: 7 - 7

18. Captopril

    Newsletter Article 09 February 2013 Pages: 7 - 8

19. Carbamazepine

    Newsletter Article 09 February 2013 Pages: 8 - 8

20. Cefalexin

    Newsletter Article 09 February 2013 Pages: 8 - 8

21. Cefazolin

    Newsletter Article 09 February 2013 Pages: 8 - 8

22. Cefoxitin/pentoxifylline

    Newsletter Article 09 February 2013 Pages: 8 - 8

23. Chlormethine/vincristine

    Newsletter Article 09 February 2013 Pages: 8 - 9

24. Cisplatin

    Newsletter Article 09 February 2013 Pages: 9 - 9

25. Cotrimoxazole

    Newsletter Article 09 February 2013 Pages: 9 - 9

26. Cyclosporin

    Newsletter Article 09 February 2013 Pages: 9 - 9

27. Dacarbazine see Doxorubicin

    Newsletter Article 09 February 2013 Pages: 9 - 9

28. Dapsone

    Newsletter Article 09 February 2013 Pages: 9 - 9

29. Diflunisal

    Newsletter Article 09 February 2013 Pages: 9 - 10

30. Digoxin interaction

    Newsletter Article 09 February 2013 Pages: 10 - 10

31. Diltiazem interaction see digoxin

    Newsletter Article 09 February 2013 Pages: 10 - 10

32. Doxorubicin / bleomycin vinblastine / dacarbazine

    Newsletter Article 09 February 2013 Pages: 10 - 10

33. Ethinyloestradiol

    Newsletter Article 09 February 2013 Pages: 10 - 11

34. Fenbufen

    Newsletter Article 09 February 2013 Pages: 11 - 11

35. Gold

    Newsletter Article 09 February 2013 Pages: 11 - 11

36. Heparin

    Newsletter Article 09 February 2013 Pages: 11 - 11

37. Ibuprofen

    Newsletter Article 09 February 2013 Pages: 11 - 11

38. Ibuprofen

    Newsletter Article 09 February 2013 Pages: 11 - 12

39. Ibuprofen overdose

    Newsletter Article 09 February 2013 Pages: 12 - 12

40. Methadone overdose

    Newsletter Article 09 February 2013 Pages: 12 - 12

41. Metoclopramide

    Newsletter Article 09 February 2013 Pages: 12 - 12

42. Mercaptopurine

    Newsletter Article 09 February 2013 Pages: 12 - 13

43. Molindone

    Newsletter Article 09 February 2013 Pages: 13 - 13

44. Nalbuphine

    Newsletter Article 09 February 2013 Pages: 13 - 13

45. Nifedipine interaction see Digoxin

    Newsletter Article 09 February 2013 Pages: 13 - 13

46. Nitrous oxide

    Newsletter Article 09 February 2013 Pages: 13 - 13

47. Pancuronium

    Newsletter Article 09 February 2013 Pages: 13 - 14

48. Phenelzine

    Newsletter Article 09 February 2013 Pages: 14 - 14

49. Propranolol interaction see Quinidine

    Newsletter Article 09 February 2013 Pages: 14 - 14

50. Quinidine interaction

    Newsletter Article 09 February 2013 Pages: 14 - 14